Metaplastic breast cancer is a very rare form of breast cancer. It is relatively uncommon. Our pathologists are often consulted by others outside of Hopkins in order to establish a diagnosis of metaplastic breast cancer, or distinguish it from other lesions for which it can be mistaken. The treatment for this cancer is generally very similar to that of invasive ductal carcinoma.
How is metaplastic breast cancer diagnosed?
Same Day Results
At the Johns Hopkins Breast Center, most women can learn within 24 hours of being seen by a breast cancer specialist whether they have breast cancer. We follow strict guidelines for biopsies and pathology reports. Patients are told the probability of cancer immediately following their biopsy procedure, and they receive a pathology confirmation within 24 hours.
Learn more about the steps of diagnosis, including:
What is the treatment for metaplastic breast cancer?
Treatment for metaplastic breast cancer can only occur after our team of breast cancer specialists determines the exact type of cancer and staging. Depending on the size and spread of the tumor(s), most women will undergo a combination of any of the following treatments:
Every day, medical science is finding advanced techniques for fighting and treating breast cancer. At Johns Hopkins Medicine, our breast cancer specialists are dedicated to developing cutting-edge techniques for surgery, breast reconstruction, chemotherapy, radiation, biologic targeted therapies and hormonal therapies.
What is the prognosis for metaplastic breast cancer?
Prognosis depends on many factors, including your individual markers and the staging of your tumor. Your medical oncologist will discuss your specific prognosis with you.